Canadian Sec - Free Realtime Quote CAD
Britannia Life Sciences Inc. (BLAB.CN)
0.0600
0.0000
(0.00%)
As of 9:41:16 AM EDT. Market Open.
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Peter James Shippen C.A.I.A., C.P.A., CFA | CEO & Director | 215.4k | -- | 1981 |
| Ms. Sarah Zilik C.A., CPA | Secretary & CFO | 132k | -- | 1980 |
| Mr. Boris Novansky | President | -- | -- | -- |
| Micah Simmons | Vice President of Corporate Development | -- | -- | -- |
Britannia Life Sciences Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
Description
Britannia Life Sciences Inc. engages in the provision of product testing, safety assessment, and compliance services primarily to the cosmetics, consumer packaged and household goods, and nutraceutical industries in the United Kingdom and internationally. The company is headquartered in Toronto, Canada.
Corporate Governance
Britannia Life Sciences Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available
Related Tickers
MOOD.CN Doseology Sciences Inc.
0.1600
0.00%
TELI.CN Telescope Innovations Corp.
0.2900
0.00%
IOT.V Innovotech Inc.
0.1300
0.00%
MBX.TO Microbix Biosystems Inc.
0.3500
0.00%
AGNPF Algernon Pharmaceuticals Inc.
0.0520
0.00%
MDMA.CN Pharmala Biotech Holdings Inc.
0.1450
0.00%
SVA.TO Sernova Biotherapeutics Inc
0.2150
-2.27%